Suppr超能文献

甘露聚糖结合凝集素 2 表现出不同的分析和生物学特性,这取决于不同的样本处理程序。

Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures.

机构信息

Laboratory of Molecular Medicine, Department of Clinical Immunology, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Mol Immunol. 2013 Dec;56(4):406-12. doi: 10.1016/j.molimm.2013.05.233. Epub 2013 Aug 1.

Abstract

Ficolin-2 (L-ficolin) is a germ line encoded pattern recognition molecule circulating in the blood, and functions as a recognition molecule in the lectin complement pathway. However, consistent and reliable measurements of Ficolin-2 concentration and activity have been difficult to achieve. After recurrent observations of deviations in Ficolin-2 properties between different blood sample procedures, we decided to investigate this closer. Blood samples from ten healthy donors were collected in various serum and plasma tubes and Ficolin-2 properties were evaluated by different ELISA setups. We found that serum prepared from tubes containing the clot activator silica used as a standard technique in many routine laboratories held a significantly lower concentration of Ficolin-2 as compared to the other sample types. Furthermore, Ficolin-2 binding and complement activation potential in this type of serum was impaired when using an acetylated compound as matrix. On the other hand, Ficolin-2 in serum made without clot activator and in plasma irrespective of additive used, had the same concentration and was capable of initiating the lectin pathway measured as C4 and C3 deposition on the ligand. No Ficolin-2 mediated formation of the terminal complement complex was observed under the applied assay conditions. In conclusion, our results show that Ficolin-2 is a promiscuous molecule and that care should be taken during sampling, handling and matrix chosen for measurement of Ficolin-2 levels and activity.

摘要

ficolin-2(L-ficolin)是一种胚系编码的模式识别分子,在血液中循环,作为凝集素补体途径中的识别分子发挥作用。然而,ficolin-2 浓度和活性的一致和可靠测量一直难以实现。在反复观察到不同血液样本处理方法之间 ficolin-2 特性的偏差后,我们决定更深入地研究这个问题。从 10 名健康供体采集了各种血清和血浆管中的血液样本,并通过不同的 ELISA 试剂盒评估 ficolin-2 特性。我们发现,与其他样本类型相比,含有作为许多常规实验室标准技术的凝结激活剂二氧化硅的管中制备的血清中 ficolin-2 的浓度明显较低。此外,当使用乙酰化化合物作为基质时,这种类型的血清中的 ficolin-2 结合和补体激活潜力受损。另一方面,在没有凝结激活剂的血清和无论使用何种添加剂的血浆中,ficolin-2 的浓度相同,并且能够启动凝集素途径,表现为配体上 C4 和 C3 的沉积。在所应用的测定条件下,未观察到 ficolin-2 介导的末端补体复合物形成。总之,我们的结果表明 ficolin-2 是一种混杂的分子,在采样、处理和选择用于测量 ficolin-2 水平和活性的基质时应小心谨慎。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验